6/6/23 |
BridgeBio (BBIO) |
Truseltiq for Gastric Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |
6/6/23 |
AstraZeneca (AZN) |
Nirsevimab for Respiratory Syncytial Virus (RSV) Prevention |
Subscribers Only |
Subscribers Only |
Subscribers Only |
6/5/23 |
Akero Therapeutics (AKRO) |
Efruxifermin for Non-Alcoholic Steatohepatitis (NASH) |
Subscribers Only |
Subscribers Only |
Subscribers Only |
6/5/23 |
Innovent Biologics (1801) |
Sintilimab for Nasopharyngeal Cancer |
Subscribers Only |
Subscribers Only |
Subscribers Only |
6/5/23 |
Ultragenyx (RARE) |
UX143 for Osteogenesis Imperfecta (OI) |
Subscribers Only |
Subscribers Only |
Subscribers Only |